Indian stock markets are set for a day of stock-specific movement on October 23, as several listed companies have shared key updates and announcements. Here’s a look at the major stocks likely to remain in focus during today’s trade session.
Top Stocks to Watch Today
-
Dr. Reddy’s Laboratories (DRL): Received a US FDA Establishment Inspection Report (EIR) with a “Voluntary Action Indicated” (VAI) for its Srikakulam unit in Andhra Pradesh.
-
Bharat Electronics Ltd (BEL): Secured an order worth ₹633 crore from Cochin Shipyard for the supply of sensors, weapon systems, fire control, and communication equipment.
-
TVS Motor: Norton Motorcycles, its UK subsidiary, unveiled a design sketch for a new flagship superbike.
-
Biocon: Biocon Biologics received approval from Health Canada for its ustekinumab biosimilar, Yesintek, referencing Stelara®.
-
ONGC & Oil India (OIL): In focus as crude prices rise, with Brent trading above $64 per barrel.
-
Ola Electric: To consider fundraising on October 25 through equity issuance or other modes.
-
United Breweries (UBL): Heineken’s quarterly update shows mid-single-digit organic net revenue growth in India.
-
Epack Prefab: Reported an order book of ₹655 crore for H1 FY26; profit after tax doubled year-on-year.
-
LG Electronics: BofA Securities Europe bought 66,700 shares via block deals.
-
JB Chemicals: CCI approved Torrent Pharma’s acquisition of the company.
-
Tata Motors: Reports suggest JLR could face a ₹6,300 crore impact from the recent cyberattack.
-
NMDC: Reduced iron ore prices by ₹500–550 per tonne effective October 22, 2025.
-
OMCs & Paint Stocks: Likely to move in line with crude price trends as Brent climbs above $64/bbl.
-
Gold Financiers: May see pressure as gold prices decline for the third straight day, slipping below $4,100/oz.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
